Cargando…

Hypothyroidism in β-Thalassemia Intermedia Patients with and without Hydroxyurea

Hydroxyurea (HU) has been successfully used in patients with β-thalassemia intermedia (β-TI). We aimed to evaluate the effect of the long-term use of HU on thyroid function in patients with β-TI. Seventy-five patients with β-TI aged≥11 years and taking HU were randomly selected during 2010 in southe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zekavat, Omid Reza, Makarem, Ali Reza, Haghpanah, Sezaneh, Karamizadeh, Zohreh, Javad, Parvin, Karimi, Mehran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Shiraz University of Medical Sciences 2014
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895896/ https://www.ncbi.nlm.nih.gov/pubmed/24453395

Ejemplares similares

Frequency of Cholelithiasis in Patients With Beta-Thalassemia Intermedia With and Without Hydroxyurea
por: Khavari, Maryam, et al.
Publicado: (2014)

Comparative Study of Radiographic and Laboratory Findings Between Beta Thalassemia Major and Beta Thalassemia Intermedia Patients With and Without Treatment by Hydroxyurea
por: Abolhasani Foroughi, Amin, et al.
Publicado: (2015)

Hydroxyurea Treatment in Transfusion-Dependent β-Thalassemia Patients
por: Bordbar, Mohammad Reza, et al.
Publicado: (2014)

Ocular findings in patients with transfusion-dependent β-thalassemia in southern Iran
por: Haghpanah, Sezaneh, et al.
Publicado: (2020)

The Frequency of Adrenal Insufficiency in Adolescents and Young Adults with Thalassemia Major versus Thalassemia Intermedia in Iran
por: Matin, Sara, et al.
Publicado: (2015)

Serum lipid profiles in patients with beta-thalassemia major and intermedia in southern Iran
por: Haghpanah, Sezaneh, et al.
Publicado: (2010)

Optical coherence tomography findings in patients with transfusion-dependent β-thalassemia
por: Haghpanah, Sezaneh, et al.
Publicado: (2022)

Relationship Between Serum Hepcidin and Ferritin Levels in Patients With Thalassemia Major and Intermedia in Southern Iran
por: Haghpanah, Sezaneh, et al.
Publicado: (2015)

The frequency of hypothyroidism and its relationship with HCV positivity in patients with thalassemia major in southern Iran
por: Haghpanah, Sezaneh, et al.
Publicado: (2018)

β-Thalassemia: New Therapeutic Modalities, Genetics, Complications, and Quality of Life
por: Karimi, Mehran, et al.
Publicado: (2012)

Side effects of hydroxyurea in patients with Thalassemia major and thalassemia intermedia and sickle cell anemia
por: Ghasemi, A, et al.
Publicado: (2014)

Acquired Vitamin K Deficiency as Unusual Cause of Bleeding Tendency in Adults: A Case Report of a Nonhospitalized Student Presenting with Severe Menorrhagia
por: Zekavat, Omid Reza, et al.
Publicado: (2017)

The survival of childhood leukemia: An 8‐year single‐center experience
por: Bordbar, Mohammadreza, et al.
Publicado: (2023)

Atopy manifestations in pediatric patients with acute lymphoblastic leukemia: correlation assessment with interleukin-4 (IL-4) and IgE level
por: Zekavat, Omid Reza, et al.
Publicado: (2022)

Skeletal complications in patients with hemophilia: a single-center experience
por: Bordbar, Mohammadreza, et al.
Publicado: (2023)

Phenotype Report on Patients with Congenital Factor V Deficiency in Southern Iran: Recent Ten Years’ Experience
por: Safarpour, Mohammad Mostafa, et al.
Publicado: (2017)

Comparison of the clinical features and outcome of children with hemophagocytic lymphohistiocytosis (HLH) secondary to visceral leishmaniasis and primary HLH: a single-center study
por: Mottaghipisheh, Hadi, et al.
Publicado: (2021)

Endocrine Function in Thalassemia Intermedia
por: Karamifar, H., et al.
Publicado: (2006)

Coronavirus Disease 2019 (COVID-19) Severity in Patients with Thalassemias: A Nationwide Iranian Experience
por: Karimi, Mehran, et al.
Publicado: (2021)

Evaluation of Knowledge of Patients with Hemophilia Regarding Their Diseases and Treatment in Iran
por: Karimi, Mehran, et al.
Publicado: (2016)

Evaluation of Metabolic Syndrome and Related Factors in Children Affected by Acute Lymphoblastic Leukemia
por: Zareifar, Soheila, et al.
Publicado: (2017)

Complementary and alternative medicine use in thalassemia patients in Shiraz, southern Iran: A cross-sectional study
por: Bordbar, Mohammadreza, et al.
Publicado: (2017)

Serum Ferritin Levels Correlation With Heart and Liver MRI and LIC in Patients With Transfusion-Dependent Thalassemia
por: Majd, Zahra, et al.
Publicado: (2015)

Thalassemia Intermedia: Chelator or Not?
por: Lee, Yen-Chien, et al.
Publicado: (2022)

Intracranial Blood Flow Velocity in Patients with β-Thalassemia Intermedia Using Transcranial Doppler Sonography: A Case-Control Study
por: Ashjazadeh, Nahid, et al.
Publicado: (2012)

β-Thalassemia Intermedia: A Bird’s-Eye View
por: Haddad, Anthony, et al.
Publicado: (2014)

Evaluation of the combination therapy of hydroxyurea and thalidomide in β-thalassemia
por: Ansari, Saqib H., et al.
Publicado: (2022)

Prevalence and Severity of Coronavirus Disease 2019 (COVID-19) in Transfusion Dependent and Non-Transfusion Dependent β -Thalassemia Patients and effects of Associated Comorbidities: An Iranian Nationwide study
por: Karimi, Mehran, et al.
Publicado: (2020)

Relationship of glucose-6-phosphate dehydrogenase deficiency and neonatal sepsis: a single-center investigation on the major cause of neonatal morbidity and mortality
por: Zekavat, Omid Reza, et al.
Publicado: (2019)

β-Thalassemia Intermedia: Interaction of α-Globin Gene Triplication With β-thalassemia Heterozygous in Spain
por: Ropero, Paloma, et al.
Publicado: (2022)

Molecular characterization of β-thalassemia intermedia in the West Bank, Palestine
por: Faraon, Rashail, et al.
Publicado: (2019)

Serum cancer antigen 15.3 concentrations in patients with betathalassemia minor compared to those with cancer and healthy individuals
por: Shahriari, Mahdi, et al.
Publicado: (2014)

CMR survey in Thalassemia Intermedia patients
por: Meloni, Antonella, et al.
Publicado: (2014)

Did the Proband Have Thalassemia Intermedia or Severe Thalassemia Trait?
por: Özsoylu, Şinasi
Publicado: (2012)

β-Thalassemia Intermedia in Northern Iraq: A Single Center Experience
por: Al-Allawi, Nasir A. S., et al.
Publicado: (2014)

Cyclic headaches in β-thalassemia intermedia case presenting as moyamoya syndrome
por: Akpınar, Süha, et al.
Publicado: (2015)

Endocrine and Bone Complications in β-Thalassemia Intermedia: Current Understanding and Treatment
por: Inati, Adlette, et al.
Publicado: (2015)

Three Mexican Families with β thalassemia intermedia with different molecular basis
por: de la Torre, Lourdes del Carmen Rizo, et al.
Publicado: (2020)

Renal Dysfunction in Pediatric Patients in Iraq With β-Thalassemia Major and Intermedia
por: Shaalan, Mohammad G, et al.
Publicado: (2022)

Stroke propensity in the Th3+/ mouse model of β-thalassemia intermedia
por: Sun, Yu-Yo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c5ti7dg0s5gm1a5i7aoc4qspv4